logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

LINGBAO GOLD (03330): The trading unit size will be changed from 2000 shares of H shares to 1000 shares of H shares.

date
18:59 12/02/2025
avatar
GMT Eight
Lingbao Gold (03330) announced that starting from 9:00 am on Thursday, March 6, 2025, it will be listed on the Hong Kong Stock Exchange...
LINGBAO GOLD (03330) announced that starting from 9:00 am on Thursday, March 6, 2025, the trading unit size for H shares traded on the Stock Exchange will be changed from 2000 shares to 1000 shares per hand.
Related Articles
HK Stock Market Move | Shandong Gold Mining (01787) rebounds over 4%; company lowers 2026 production guidance; institutions say performance is expected to grow strongly as production recovers.
HK Stock Market Move | JUNSHI BIO(01877) Rises Over 4% on Strategic Cooperation with Meijie Medical to Explore "Multimodal Drug-Device Combination" in Tumor Treatment
Shenwan Hongyuan Group: Initiates coverage on MOBVISTA (01860) with a "Buy" rating, target market cap of US$4.4 billion.
HK Stock Market Move | Shandong Gold Mining (01787) rebounds over 4%; company lowers 2026 production guidance; institutions say performance is expected to grow strongly as production recovers.
HK Stock Market Move | JUNSHI BIO(01877) Rises Over 4% on Strategic Cooperation with Meijie Medical to Explore "Multimodal Drug-Device Combination" in Tumor Treatment
Shenwan Hongyuan Group: Initiates coverage on MOBVISTA (01860) with a "Buy" rating, target market cap of US$4.4 billion.
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.